‘Nothing is hopeless; we must hope for everything.’
- Euripides, 480 B.C. to 406 B.C.
New data…
From 1993 to 1997, testicular cancer was 10% greater among those who used digital Cellular Phones in Sweden than it was among those who did not use digital Cellular Phones (latency period >1 year), per Hardell et al in 2007.
1st Author Yoon-Jung Choi omitted the percentage, and described it only-generally as “a statistically significant positive association”.
From 1997 to 2003, malignant brain tumors were 40% greater among digital Cellular Phone users in Sweden than they were among those who did not use digital Cellular Phones (latency period >1 year), per Hardell et al in 2010.
From 1997 to 2003, Leukemia was 50% greater among digital Cellular Phone users in Thailand than it was among those who did not use Cellular Phones, per Kaufman et al. in 2009.
From 1993 to 2000, epithelial parotid gland malignancies were 14% greater among regular users of cellular phones in China than they were among those who never or rarely used cellular phones, per Duan et al in 2011.
From 1997 to 2000, brain tumors were 21% greater among digital Cellular Phone users in Sweden than they were among those who did not use digital Cellular Phones ((latency period >1 year), per Hardell et al in 2003.
1st Author Yoon-Jung Choi omitted the percentage, and described it only-generally as “a statistically significant positive association”.
From 1999 to 2002, Non-Hodgkin’s lymphoma was 4% greater among digital Cellular Phone users in Sweden than it was among those who did not use digital Cellular Phones (latency period >1 year), per Hardell et al in 2005.
1st Author Yoon-Jung Choi omitted the percentage, and described it only-generally as “a statistically significant positive association”.
From 2000 to 2010, vestibular schwannoma was 14% greater among regular users of cellular phones in Brazil than it was among those who did not use/or irregulary used cellular phones, per Corona et al in 2012.
From 2000 to 2004, glioma were 29% greater among digital Cellular Phone users in Japan than they were among those who did not use digital Cellular Phones, per Takebayashi et al. in 2008.
From 2000 to 2003, the 50% positive variance in malignant brain tumors among digital Cellular Phone users in Sweden versus those who did not use digital Cellular Phones was 25% greater than its 40% positive variance from 1997 to 2000.
From 2000 to 2003 versus 2007 to 2009, the 40% positive variance in malignant brain tumors among digital Cellular Phone users in Sweden versus those who did not use digital Cellular Phones was 60% greater than its 25% positive variance from 1997 to 2003 versus 2000 to 2003.
From 2000 to 2003, malignant brain tumors were 90% greater, or almost two times greater among those who used digital Cellular Phones in Sweden than they were among those who did not use digital Cellular Phones (latency period >1 year), per Hardell et al in 2006.
1st Author Yoon-Jung Choi omitted the percentage, and described it only-generally as “a statistically significant positive association”.
From 2002 to 2007, glioma was 17% greater among mobile phone users in Korea than it was among who did not use mobile phones, per Yoon et al in 2015.
From 2002 to 2007, acoustic neuroma was 26% greater among regular users of cellular phones in Sweden than it was among those who never used or rarely used digital cellular phones, per Pettersson et al in 2014.
From 2003 to 2009, Leukemia was 6% greater among mobile phone users in the UK than it was among those who did not use mobile phones, per Cooke et al in 2010.
From 2004 to 2008, brain umors were 36% greater among regular users of mobile phones in Denmark, Norway, Sweden, and Switzerland than they were among those who did not use mobile phones, per Aydin et al in 2011.
From 2004 to 2006, glioma was 24% greater among regular users of cellular phones in France than it was among those who did not use mobile phones, per Coureau et al in 2014.
In 2005, brain cancer was 7% greater among Cellular Phone users in France >36 hours per year than it was among those who did not use Cellular Phones.
From 2007 to 2009, the 70% positive variance in malignant brain tumors among digital Cellular Phone users in Sweden versus those who did not use digital Cellular Phones was 40% greater than its 50% positive variance from 2000 to 2003.
From 2007 to 2009, malignant brain tumors were 70% greater among digital Cellular Phone users in Sweden than they were among those who did not use digital Cellular Phones (latency period >1 year), per Hardell et al in 2013.
Jeff Miller, Pittsburgh, PA, May 5, 2025
If you’d like to be added to this free mailing list, please send me a note at [email protected]
